126 related articles for article (PubMed ID: 15461812)
1. Apolipoprotein M.
Luo G; Zhang X; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2004 Oct; 3():21. PubMed ID: 15461812
[TBL] [Abstract][Full Text] [Related]
2. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
[TBL] [Abstract][Full Text] [Related]
3. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of apolipoprotein M during mouse and human embryogenesis.
Zhang XY; Jiao GQ; Hurtig M; Dong X; Zheng L; Luo GH; Nilsson-Ehle P; Ye Q; Xu N
Acta Histochem; 2004; 106(2):123-8. PubMed ID: 15147633
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein M: progress in understanding its regulation and metabolic functions.
Christoffersen C; Dahlbäck B; Nielsen LB
Scand J Clin Lab Invest; 2006; 66(7):631-7. PubMed ID: 17101555
[TBL] [Abstract][Full Text] [Related]
6. Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects.
Xu N; Nilsson-Ehle P; Ahrén B
J Nutr Biochem; 2004 Oct; 15(10):579-82. PubMed ID: 15542348
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
[TBL] [Abstract][Full Text] [Related]
8. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization.
Zhang XY; Dong X; Zheng L; Luo GH; Liu YH; Ekström U; Nilsson-Ehle P; Ye Q; Xu N
Acta Histochem; 2003; 105(1):67-72. PubMed ID: 12666989
[TBL] [Abstract][Full Text] [Related]
9. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M.
Faber K; Hvidberg V; Moestrup SK; Dahlbäck B; Nielsen LB
Mol Endocrinol; 2006 Jan; 20(1):212-8. PubMed ID: 16099815
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein M likely extends its anti-atherogenesis via anti-inflammation.
Huang XS; Zhao SP; Hu M; Luo YP
Med Hypotheses; 2007; 69(1):136-40. PubMed ID: 17218068
[TBL] [Abstract][Full Text] [Related]
11. An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA.
Cervin C; Axler O; Holmkvist J; Almgren P; Rantala E; Tuomi T; Groop L; Dahlbäck B; Karlsson E
J Intern Med; 2010 Mar; 267(3):316-21. PubMed ID: 19754856
[TBL] [Abstract][Full Text] [Related]
12. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
Yang L; Zhao S
Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
[TBL] [Abstract][Full Text] [Related]
13. Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells.
Luo G; Hurtig M; Zhang X; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2005 May; 1734(2):198-202. PubMed ID: 15904876
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Apolipoprotein M Serum Concentration as a Biomarker of HNF-1alpha MODY.
Skupien J; Kepka G; Gorczynska-Kosiorz S; Gebska A; Klupa T; Wanic K; Nowak N; Borowiec M; Sieradzki J; Malecki MT
Rev Diabet Stud; 2007; 4(4):231-5. PubMed ID: 18338076
[TBL] [Abstract][Full Text] [Related]
15. A novel human apolipoprotein (apoM).
Xu N; Dahlbäck B
J Biol Chem; 1999 Oct; 274(44):31286-90. PubMed ID: 10531326
[TBL] [Abstract][Full Text] [Related]
16. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
[TBL] [Abstract][Full Text] [Related]
18. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin.
Xu N; Nilsson-Ehle P; Ahrén B
Biochem Biophys Res Commun; 2006 Apr; 342(4):1174-7. PubMed ID: 16516154
[TBL] [Abstract][Full Text] [Related]
19. ApoM: gene regulation and effects on HDL metabolism.
Nielsen LB; Christoffersen C; Ahnström J; Dahlbäck B
Trends Endocrinol Metab; 2009 Mar; 20(2):66-71. PubMed ID: 19200746
[TBL] [Abstract][Full Text] [Related]
20. Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness.
Dullaart RP; Plomgaard P; de Vries R; Dahlbäck B; Nielsen LB
Clin Chim Acta; 2009 Aug; 406(1-2):129-33. PubMed ID: 19539616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
